CCAP logo

Crescent Capital BDC, Inc. Stock Price

NasdaqGM:CCAP Community·US$365.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CCAP Share Price Performance

US$9.92
-5.89 (-37.25%)
​
US$14.00
Fair Value
US$9.92
-5.89 (-37.25%)
29.1% undervalued intrinsic discount
US$14.00
Fair Value
Price US$9.92
AnalystHighTarget US$14.00
AnalystLowTarget US$11.00
AnalystConsensusTarget US$12.25

CCAP Community Narratives

Fair Value
·
Fair Value US$14 29.1% undervalued intrinsic discount

Private Credit Tailwinds And First Lien Focus Will Support A Stronger Future

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Fair Value
·
Fair Value US$11 9.8% undervalued intrinsic discount

Private Credit Adoption And Covenant Strength Will Shape Future Earnings Stability

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Fair Value
·
Fair Value US$12.25 19.0% undervalued intrinsic discount

Private Credit Demand And Stable Funding Structure Will Support Long-Term Earnings Resilience

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
CCAP logo
Crescent Capital BDC
29.1% undervalued intrinsic discount

Private Credit Tailwinds And First Lien Focus Will Support A Stronger Future

View narrative
Updated 27 Aug
Read Narrative
CCAP logo
Crescent Capital BDC
19.0% undervalued intrinsic discount
Updated

Private Credit Demand And Stable Funding Structure Will Support Long-Term Earnings Resilience

View narrative
Updated 10 Sep
Read Narrative
CCAP logo
Crescent Capital BDC
9.8% undervalued intrinsic discount

Private Credit Adoption And Covenant Strength Will Shape Future Earnings Stability

View narrative
Updated 12 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Updated Narratives

CCAP logo

CCAP: Higher Profitability And Special Dividends Will Support Bullish Outlook

Fair Value: US$12.25 19.0% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCAP logo

CCAP: Higher Margins And Special Dividends Will Support Future Upside

Fair Value: US$14 29.1% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CCAP logo

CCAP: Special Dividend And Adjusted Earnings Outlook Will Shape Balanced Return Potential

Fair Value: US$11 9.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Moderate growth potential and slightly overvalued.

2 Risks
2 Rewards
View Full Analysis

Crescent Capital BDC, Inc. Key Details

US$156.4m

Revenue

US$0

Cost of Revenue

US$156.4m

Gross Profit

US$159.6m

Other Expenses

-US$3.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.086
100.00%
-2.03%
141.1%
View Full Analysis

About CCAP

Founded
2015
Employees
n/a
CEO
Jason Breaux
WebsiteView website
www.crescentbdc.com

Crescent Capital BDC, Inc. is as a business development company is a private debt fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Recent CCAP News & Updates

Narrative Update • Sep 10

CCAP: Higher Profitability And Special Dividends Will Support Bullish Outlook

Analysts have trimmed their price target for Crescent Capital BDC from $14.00 to $12.25, citing updated assumptions related to discount rates, revenue trends, profit margins and expected P/E levels. What’s in the News for Crescent Capital BDC Crescent Capital BDC has been dropped from the NASDAQ Composite Index, according to a key developments update.
Seeking Alpha • Sep 01

Crescent Capital BDC: Cheap For Good Reason, Still A Hold

Summary Crescent Capital BDC is rated HOLD, with the stock trading at a record 0.600x NAV and an attractive 12.7% yield. The dividend was reset 19% lower to $0.34, now conservatively covered by NII at 1.06x, and management permanently cut fees. Portfolio credit quality remains pressured: NAV has declined for eight straight quarters, non-accruals are 4.8%, and the watch list is 14.7%. I am waiting for one quarter of flat NAV before upgrading to BUY, as the book's deterioration remains the key risk. Read the full article on Seeking Alpha
Narrative Update • Aug 27

CCAP: Higher Margins And Special Dividends Will Support Future Upside

Analysts have trimmed their price target on Crescent Capital BDC to $14 from $16, citing updated assumptions that reflect a slightly higher discount rate, a smaller projected revenue decline, a higher profit margin, and a lower expected future P/E multiple. What's in the News Crescent Capital BDC has been dropped from the NASDAQ Composite Index, according to a key index constituent update.

Recent updates

No updates

Crescent Capital BDC, Inc. Competitors

SEMU.F logo

Siem Industries

Symbol: OTCPK:SEMU.F
Market cap: US$1.0b
LU logo

Lufax Holding

Symbol: NYSE:LU
Market cap: US$1.0b
QFIN logo

Qfin Holdings

Symbol: NasdaqGS:QFIN
Market cap: US$1.0b
VRTS logo

Virtus Investment Partners

Symbol: NYSE:VRTS
Market cap: US$1.0b
View more competitors